Sotera Health Q3 revenue beats estimates on pricing and volume
SHC•Sotera Health’s third-quarter revenue rose 4.4% year over year to $324.89 million, beating estimates, while adjusted EPS increased 12% to $0.29. The company reaffirmed its 2026 outlook, including revenue of $1.233 billion to $1.250 billion and adjusted EPS of $0.95 to $1.01.
1. Quarterly results
Sotera Health reported third-quarter revenue of $324.89 million, above the $319.77 million analyst estimate, and adjusted EPS of $0.29, compared with an estimate of $0.27. Revenue increased 4.4% year over year, and adjusted EPS rose 12%.
2. 2026 outlook
The company reaffirmed its 2026 net revenue outlook of $1.233 billion to $1.250 billion, representing growth of 5.25% to 6.75%. It maintained its adjusted EBITDA forecast of $632 million to $641 million, up 5.75% to 7.25%, and adjusted EPS outlook of $0.95 to $1.01.
3. Revenue drivers
Sotera said higher pricing, improved volume and mix, and a foreign currency benefit drove third-quarter revenue growth. Nordion segment revenue declined due to the expected timing of Cobalt-60 harvest schedules. Segment income margin benefited from operational productivity and favorable pricing, partly offset by inflation.
